Infection by Virus West Nile: Complete ICD-11 Coding Guide
1. Introduction
West Nile virus infection represents one of the most widely distributed arboviruses geographically in the world, constituting a significant challenge for global public health. This viral disease, transmitted primarily by mosquitoes of the genus Culex, presents a variable clinical spectrum that can range from asymptomatic infections to severe and potentially fatal neurological manifestations.
West Nile virus was first identified in 1937 in the Western Nile region, from which its name is derived. Since then, it has expanded to all continents except Antarctica, establishing itself as an endemic threat in diverse regions. Most infected individuals remain asymptomatic; however, approximately 20% develop flu-like symptoms, and about 1 in 150 infections progresses to severe neuroinvasive disease, including meningitis, encephalitis, or acute flaccid paralysis.
The clinical importance of this infection lies not only in its prevalence but also in the potential severity of neurological complications, which can result in permanent sequelae or death. Groups at highest risk include the elderly, immunocompromised individuals, and people with chronic comorbidities. Transmission occurs primarily during the warmer months, when the activity of vector mosquitoes is most intense.
Correct coding of West Nile virus infection is critical for epidemiological surveillance, appropriate allocation of public health resources, planning of vector control strategies, and clinical research. Precision in documentation allows for early identification of outbreaks, evaluation of the effectiveness of preventive interventions, and ensuring appropriate treatment for affected patients.
2. Correct ICD-11 Code
The specific ICD-11 code for this condition is 1D46 - West Nile virus infection, classified within the superior category "Some arthropod-borne viral fevers". This code represents a precise and internationally standardized classification that facilitates communication between healthcare professionals and medical information systems globally.
The official definition establishes that West Nile virus infection is a mosquito-transmitted viral infection with flu-like symptoms, where approximately 1 in 150 infections will result in severe neurological disease, with treatment being essentially supportive. This definition encompasses the entire spectrum of the disease, from mild forms to neuroinvasive manifestations.
Code 1D46 should be used whenever there is laboratory confirmation of West Nile virus infection or when the clinical-epidemiological diagnosis is sufficiently robust. The ICD-11 classification allows for more specific identification compared to previous systems, facilitating epidemiological studies and analyses of temporal and geographic disease trends.
It is fundamental that healthcare professionals understand that this code applies to all clinical forms of infection, including asymptomatic cases diagnosed by serological screening, West Nile fever (non-neurological symptomatic form), and West Nile neuroinvasive disease (encephalitis, meningitis, or acute flaccid paralysis).
3. When to Use This Code
Code 1D46 should be applied in specific clinical scenarios that demonstrate evidence of West Nile virus infection. Below, we present detailed practical situations:
Scenario 1: Confirmed West Nile Fever A 45-year-old patient presents with acute fever for 4 days, accompanied by intense headache, myalgia, arthralgia, and maculopapular rash on the trunk. Reports frequent mosquito bites over the past two weeks. Serological tests demonstrate positive IgM for West Nile virus, confirming recent infection. This is the classic scenario for using code 1D46, as there is laboratory confirmation and compatible clinical presentation.
Scenario 2: Meningitis Due to West Nile Virus A 68-year-old patient with high fever, neck stiffness, photophobia, and altered level of consciousness. Lumbar puncture reveals lymphocytic pleocytosis with elevated proteins. PCR of cerebrospinal fluid detects viral RNA of West Nile virus. In this case, code 1D46 is appropriate for documenting the etiology of meningitis and may be supplemented with an additional code specifying the neurological manifestation.
Scenario 3: Neuroinvasive Encephalitis An elderly patient presenting with mental confusion, tremors, progressive muscle weakness, and seizures. Brain magnetic resonance imaging shows inflammatory changes in gray matter. Serology confirms acute infection with West Nile virus. Code 1D46 is essential for recording this severe form of the disease, fundamental for epidemiological notification.
Scenario 4: Associated Acute Flaccid Paralysis A 52-year-old patient develops asymmetric weakness in lower limbs following a febrile illness, progressing to flaccid paralysis. Electromyoneurography suggests lower motor neuron involvement. Serological tests confirm West Nile virus infection. Code 1D46 appropriately documents this specific neurological manifestation of the infection.
Scenario 5: Asymptomatic Infection Detected on Screening An asymptomatic blood donor with positive screening test for West Nile virus through viral nucleic acid detection. Although without symptoms, there is evidence of active infection, justifying the use of code 1D46 for surveillance and transfusion control purposes.
Scenario 6: Febrile Syndrome During Epidemic Period During a documented outbreak, a patient presents with fever, headache, and myalgia with compatible epidemiology (mosquito exposure in endemic area). Even with confirmatory tests pending, the clinical-epidemiological diagnosis may justify provisional use of code 1D46, especially for rapid notification to health authorities.
4. When NOT to Use This Code
It is essential to understand the situations where code 1D46 should not be applied to avoid classification errors that compromise epidemiological data and clinical management:
Other Febrile Arboviroses: Do not use 1D46 for infections caused by dengue, zika, chikungunya, or yellow fever, even if they present with similar symptomatology. Each has a specific code in ICD-11. Differentiation requires laboratory confirmation, as clinical presentation may be indistinguishable by clinical criteria alone.
Meningitis or Encephalitis of Other Etiologies: When etiological investigation identifies other causative agents (enterovirus, herpes virus, bacteria), the appropriate code should reflect the specific identified agent. Do not presume West Nile virus infection without robust laboratory or epidemiological evidence.
Nonspecific Febrile Syndromes Without Confirmation: Acute febrile conditions without laboratory confirmation and without suggestive epidemiology should not receive code 1D46. Use codes for fever of undetermined origin or nonspecific febrile syndrome until further investigation is conclusive.
Late Sequelae Without Active Infection: Patients with neurological sequelae from previous West Nile virus infection (such as residual weakness or cognitive deficits) should not receive code 1D46 in the chronic phase. Use appropriate codes for neurological sequelae, and may mention the historical etiology in clinical documentation.
Exposure Without Documented Infection: Individuals with a history of exposure to mosquitoes in endemic areas but without clinical or laboratory evidence of infection should not be coded with 1D46. Mere exposure to risk does not constitute a diagnosis.
5. Coding Step by Step
Step 1: Assess Diagnostic Criteria
Confirmation of West Nile virus infection diagnosis requires a systematic approach combining clinical, epidemiological, and laboratory elements. Begin by evaluating the clinical presentation: sudden onset fever, headache, myalgia, arthralgia, possible rash, and in severe cases, neurological manifestations such as altered level of consciousness, neck stiffness, tremors, muscle weakness, or paralysis.
Investigate the epidemiological history in detail: recent mosquito exposure, residence or travel to areas with known transmission, time of year compatible with increased vector activity, and knowledge of cases in the community. This epidemiological context is crucial, especially when laboratory tests are not immediately available.
Essential diagnostic tools include serology for detection of specific IgM and IgG antibodies, with positive IgM indicative of recent infection. PCR for detection of viral RNA can be performed on blood, cerebrospinal fluid, or other body fluids, offering definitive confirmation. In neuroinvasive cases, lumbar puncture with cerebrospinal fluid analysis is fundamental, as well as neuroimaging (magnetic resonance imaging or computed tomography).
Step 2: Verify Specifiers
Although code 1D46 does not have formal subdivisions in ICD-11, it is important to document relevant clinical specifiers. Classify severity: asymptomatic infection, West Nile fever (symptomatic non-neurological) or neuroinvasive disease (meningitis, encephalitis, or acute flaccid paralysis).
Record symptom duration and disease phase: acute (first days), subacute (weeks), or convalescence. Document specific features such as presence of rash, gastrointestinal symptoms, lymphadenopathy, or ocular manifestations. In neuroinvasive cases, specify the type of involvement: aseptic meningitis, encephalitis with or without seizures, acute flaccid paralysis with specific anatomical distribution.
Step 3: Differentiate from Other Codes
Differentiation from 1D40 (Chikungunya virus disease): Chikungunya is characterized by intense arthralgia and polyarthritis that may persist for months, being more prominent than in West Nile infection. Joint involvement is typically bilateral and symmetric, affecting small joints of the hands and feet. Neuroinvasive manifestations are rare in chikungunya, whereas they represent the most serious complication of West Nile.
Differentiation from 1D41 (Colorado tick fever): This disease is transmitted by ticks, not mosquitoes, making a history of tick exposure in specific mountainous areas crucial. It presents a characteristic biphasic pattern ("saddle fever"), with two fever peaks separated by an afebrile period. Leukopenia and thrombocytopenia are more pronounced than in West Nile.
Differentiation from 1D42 (O'nyong-nyong fever): Disease geographically restricted to specific regions of Africa, transmitted mainly by Anopheles mosquitoes. It is characterized by severe arthralgia similar to chikungunya, with prominent generalized lymphadenopathy. Severe neuroinvasive manifestations are exceptionally rare, unlike West Nile.
Step 4: Required Documentation
Adequate documentation should include a complete checklist: date of symptom onset, detailed description of symptoms, exposure history (location, date, risk activities), results of all laboratory tests with collection dates, neuroimaging findings when applicable, and clinical course.
Specifically record the diagnostic methods used: type of serological test (ELISA, immunofluorescence), quantitative results when available, PCR with specification of the sample tested, cerebrospinal fluid analysis with cellularity, biochemistry, and microbiology. Document treatments instituted, therapeutic response, complications, and clinical outcome.
For purposes of compulsory notification, ensure that all mandatory fields are completed, including demographic data, probable location of infection, severity classification, and outcome. This robust documentation is essential for epidemiological surveillance and research.
6. Complete Practical Example
Clinical Case
A 62-year-old male patient, a farmer, seeks medical care with a presentation of high fever (39.5°C) for 3 days, accompanied by intense headache, photophobia, generalized myalgia, and nausea. He reports that over the past two weeks he has been working in a rural area near a water reservoir, with intense mosquito presence, being bitten frequently at dusk.
On physical examination, he presents febrile, oriented but drowsy, with mild neck stiffness. A discrete maculopapular rash is noted on the trunk and upper extremities. Absence of focal neurological signs. Cervical lymph nodes slightly enlarged and painless. Remainder of examination without significant abnormalities.
Due to suspicion of viral meningoencephalitis, a lumbar puncture was performed, revealing cerebrospinal fluid with lymphocytic pleocytosis (120 cells/mm³, 85% lymphocytes), elevated proteins (80 mg/dL), and normal glucose. Complete blood count showed mild leukopenia. Serology collected on the fifth day of symptoms demonstrated positive IgM for West Nile virus, confirming recent infection. PCR of the cerebrospinal fluid also detected West Nile viral RNA.
Brain magnetic resonance imaging revealed discrete edema in gray matter of the thalamus and basal ganglia, compatible with viral encephalitis. The patient was hospitalized for supportive care, intravenous hydration, analgesia, and neurological monitoring. He evolved with gradual improvement after 7 days, being discharged with guidance and outpatient follow-up.
Step-by-Step Coding
Criteria Analysis: The patient presents all elements necessary for diagnostic confirmation: acute febrile syndrome with neurological manifestations (neck stiffness, drowsiness), compatible epidemiological history (intense exposure to mosquitoes in rural area during transmission period), definitive laboratory confirmation (positive IgM serology and PCR detecting viral RNA), and neuroimaging findings compatible with viral encephalitis.
Code Selected: 1D46 - West Nile virus infection
Complete Justification: Code 1D46 is the most appropriate because there is unequivocal laboratory confirmation through two distinct methods (serology and molecular biology), characteristic clinical presentation of neuroinvasive disease from West Nile virus (meningoencephalitis), robust epidemiological context, and exclusion of other common viral etiologies. The presence of central nervous system involvement classifies this case as a severe form of infection.
Complementary Codes: One may consider adding a specific code for viral encephalitis to detail the main clinical manifestation, although code 1D46 already encompasses all forms of infection. For statistical and surveillance purposes, it is recommended to separately document the classification as "West Nile neuroinvasive disease," an important epidemiological category for public health.
7. Related Codes and Differentiation
Within the Same Category
1D40: Chikungunya virus disease Use code 1D40 when there is confirmed chikungunya virus infection, characterized mainly by severe arthralgia and polyarthritis, frequently bilateral and symmetric, affecting small joints. The main difference compared to 1D46 lies in the prominence and persistence of joint involvement (which may last months) and the rarity of severe neuroinvasive manifestations. Chikungunya is also mosquito-transmitted, but primarily by Aedes aegypti and Aedes albopictus, whereas West Nile is transmitted by Culex.
1D41: Colorado tick fever Code 1D41 should be used for Colorado tick fever virus infection, transmitted by Dermacentor andersoni ticks. The fundamental difference versus 1D46 lies in the vector (tick versus mosquito), geographic distribution restricted to specific mountainous regions, and characteristic biphasic fever pattern. History of tick exposure and temporal pattern of fever are key elements for differentiation.
1D42: O'nyong-nyong fever Use 1D42 for O'nyong-nyong virus infection, geographically limited to specific African regions. The main difference compared to 1D46 lies in restricted geographic distribution, severe arthralgia similar to chikungunya, prominent generalized lymphadenopathy, and absence of severe neuroinvasive manifestations. The vector also differs, being primarily Anopheles mosquitoes.
Differential Diagnoses
Other conditions that may mimic West Nile virus infection include viral meningitis from enteroviruses (more common in children, usually self-limited), herpetic encephalitis (requires urgent specific antiviral treatment), infections by other regional arboviruses, and Guillain-Barré syndrome (ascending flaccid paralysis without fever in the acute phase). Differentiation requires specific laboratory confirmation and careful evaluation of the epidemiologic context.
8. Differences with ICD-10
In ICD-10, West Nile virus infection was coded as A92.3 - West Nile virus infection, within the category of viral fevers transmitted by mosquitoes. The transition to ICD-11 maintained a specific code for this condition, now as 1D46, reflecting the global epidemiological importance of this arbovirus.
The main changes in ICD-11 include a clearer and more logical hierarchical structure, facilitating navigation among related codes, and more standardized international definitions. ICD-11 offers greater flexibility for documentation of clinical specifiers and allows better integration with electronic health systems.
The practical impact of these changes is positive for epidemiological surveillance, as more precise classification facilitates international comparisons and temporal trend analyses. For healthcare professionals, the transition requires updating knowledge about the new code structure, but the coding logic remains fundamentally similar. Health information systems need to be updated to incorporate the new classification, a process that occurs gradually in different jurisdictions.
9. Frequently Asked Questions
How is West Nile virus infection diagnosed? Diagnosis combines clinical evaluation, epidemiological history, and laboratory confirmation. Clinically, suspicion arises in the presence of acute febrile syndrome with headache, myalgia, and possible neurological manifestations, especially during periods of active transmission. Laboratory confirmation is made primarily through serology detecting specific IgM antibodies (indicative of recent infection) or PCR identifying viral RNA in blood or cerebrospinal fluid. In neuroinvasive cases, cerebrospinal fluid analysis and neuroimaging complement the investigation.
Is there specific treatment for West Nile virus infection? There is no approved specific antiviral treatment for West Nile virus infection. Management is essentially supportive, focusing on adequate hydration, symptom control (analgesics, antipyretics), and careful monitoring. In severe neuroinvasive cases, hospitalization is necessary for respiratory support if there is bulbar involvement, seizure control when present, and prevention of complications. Most patients with non-neurological forms recover completely with symptomatic outpatient care.
Is treatment available in public health systems? Since treatment is essentially supportive, the necessary resources (hydration, analgesics, antipyretics) are widely available in public health systems globally. Severe cases requiring hospitalization and intensive care depend on local hospital infrastructure, which varies among different regions. The main challenge is not the availability of specific treatments (which do not exist), but rather diagnostic laboratory capacity and resources for managing severe neurological complications.
How long does treatment and recovery last? Duration varies according to severity. Non-neurological forms generally resolve in 7 to 10 days, with complete recovery in 2 to 3 weeks. Neuroinvasive cases may require prolonged hospitalization (2 to 4 weeks or longer) and convalescence of several months. Some patients, especially elderly individuals with severe encephalitis, may develop permanent neurological sequelae such as muscle weakness, cognitive deficits, or chronic fatigue. Long-term neurological follow-up is recommended for severe cases.
Can this code be used in medical certificates? Yes, code 1D46 can and should be used in medical certificates when appropriate, especially to justify work absence. The duration of absence depends on severity: mild forms may require 7 to 14 days, while neuroinvasive cases may require prolonged absence of several months. Proper documentation with the correct ICD-11 code is important for social security and labor purposes, ensuring that the patient receives appropriate benefits during the recovery period.
How to prevent West Nile virus infection? Prevention is based mainly on vector control measures and individual protection against mosquito bites. Use insect repellents containing effective components, wear long-sleeved clothing and pants during periods of greater mosquito activity (dusk and dawn), install screens on windows and doors, and eliminate mosquito breeding sites by removing standing water in containers. There is no vaccine available for human use, although one exists for equines in some regions. Community mosquito control programs are fundamental to reducing transmission in endemic areas.
Who is at greater risk of developing severe disease? Groups at highest risk for neuroinvasive disease include people over 60 years of age (risk increases significantly with age), immunosuppressed individuals (transplant recipients, cancer patients, HIV/AIDS), people with chronic diseases (diabetes, hypertension, kidney disease), and possibly individuals with certain genetic factors. Pregnant women also require special attention due to the theoretical risk of vertical transmission, although it is rare. These groups should be especially vigilant regarding preventive measures during transmission periods.
Does infection confer permanent immunity? West Nile virus infection generally confers durable, possibly permanent, immunity against reinfection by the same virus. Protective antibodies persist for years after initial infection. Documented cases of reinfection are extremely rare. However, immunity may be less robust in severely immunosuppressed individuals. This durable immunity is epidemiologically important, as populations in endemic areas gradually develop herd immunity, although new susceptible individuals (children, migrants) remain at risk.
Conclusion: Proper coding of West Nile virus infection using ICD-11 code 1D46 is fundamental for effective epidemiological surveillance, clinical research, and appropriate public health resource management. Understanding when to apply this code, differentiating it from similar conditions, and properly documenting all clinical aspects are essential competencies for health professionals. Accuracy in coding directly contributes to better understanding of the global distribution of this important arbovirus and implementation of effective preventive strategies.
External References
This article was prepared based on reliable scientific sources:
- 🌍 WHO ICD-11 - West Nile Virus Infection
- 🔬 PubMed Research on West Nile Virus Infection
- 🌍 WHO Health Topics
- 📋 CDC - Centers for Disease Control
- 📊 Clinical Evidence: West Nile Virus Infection
- 📋 Ministry of Health - Brazil
- 📊 Cochrane Systematic Reviews
References verified on 2026-02-04